LivaNova PLC

NASDAQ:LIVN

Medical - Devices

Healthcare
$94.54 +0.96%

+$0.76 today

Market cap
$5.21B
Beta
0.88
P/E (TTM)
40.5
EPS (TTM)
$1.96
52W Low $41.02High $80.96

Volume 1.32M

Average 0.79M

LIVN Net Receivables

Amounts owed to the company by customers and others, net of allowances for uncollectible accounts.

LivaNova PLCNASDAQ: LIVN

Net Receivables · Q3 FY2026 · quarter ended Sep 2026

Net receivables rises 18.2% from a year ago

Net receivables stood at $282.7M at the end of Q3 FY2026, up 18.2% from a year earlier and up 3.1% from the prior quarter. Over 3 fiscal years it compounded at +0.2% a year.

Context

  • Net receivables amounted to 10.4% of total assets at the end of Q3 FY2026, up 1.1 pp from a year earlier.
  • Net receivables increased in 2 of the last 3 fiscal years.

What to watch

Whether net receivables keeps rising in the next quarterly balance sheet after a +18.2% change from a year earlier.

Sources:Balance SheetText generated from reported figures; not investment advice.

Latest quarterSep 2026
$282.7M+3.1% QoQ
Last fiscal yearDec 2025
$216M-3.4% YoY
Year agoSep 2025
$239.11M+18.2% since
Net Receivables past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+18.2%——
1 year-3.4%——
3-year CAGR+0.2%——
5-year CAGR——
10-year CAGR——

Net Receivables history

USD · from the balance sheet

Latest · FY2025
216M USD
Year-over-year change
-3.4%
4-year CAGR
-0.8%

Net Receivables vs competitors

How LIVN compares with its peers on the latest reported figures

  • LIVN's Sep 2026 net receivables of $282.7M is the 4th highest of the 10 companies compared; the peer median is $216.07M.
  • Its year-over-year change of +18.2% is the highest of 10, against a peer median of +1.0%.
  • Net receivables amounts to 10.4% of total assets for LIVN, versus a peer median of 9.1%.
LIVN Competitors Peer median
Net Receivables for LIVN and competitors
Company Period Latest balance YoY 3-year CAGR% of assets
BSXBoston Scientific CorporationJun 2026$3.05B +8.3%+14.1%6.7%
RMDResMed Inc.Jun 2026$1.04B +4.6%+13.7%11.6%
EWEdwards Lifesciences CorporationJun 2026$955.7M +5.9%+9.3%6.9%
LIVNLivaNova PLCSep 2026$282.7M +18.2%+0.2%10.4%
MDTMedtronic plcJul 2026$224M -96.4%+3.5%0.2%
HAEHaemonetics CorporationJun 2026$216.07M +7.6%+6.6%9.1%
INSPInspire Medical Systems, Inc.Jun 2026$103.34M -24.9%+25.0%11.2%
STIMNeuronetics, Inc.Mar 2026$16.21M -39.7%+6.9%12.9%
NPCENeuroPace, Inc.Mar 2026$14.79M -4.2%+25.2%15.0%
CVRXCVRx, Inc.Mar 2026$9.1M +1.0%+24.7%9.1%
MOBIMobia Medical, Inc. Common Stock—— ———
Peer median (excluding LIVN) $216.07M+1.0%+13.7%9.1%

Competitors are the stored peer set for LIVN. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Balance Sheet

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Cash & Equivalents207.99M214.17M266.5M428.86M635.6M
Short-term Investments00000
Net Receivables222.98M214.82M215.07M223.7M216M
Inventory105.84M129.38M147.89M147.57M164.7M
Other Current Assets104.75M296.06M311.37M327.06M85.3M
Total Current Assets679.18M886.14M988.16M1.13B1.1B
Property, Plant & Equipment (Net)190.67M183.02M205.03M217.1M298.1M
Goodwill899.53M768.79M782.94M750.01M792.8M
Intangible Assets399.68M368.56M261.18M237.29M230M
Long-term Investments16.6M16.27M22.84M25.08M20.3M
Tax Assets2.2M1.38M118.86M111.86M111M
Other Non-current Assets13.1M70.62M50.56M37.87M52.3M
Total Non-current Assets1.52B1.41B1.44B1.38B1.5B
Total Assets2.2B2.29B2.43B2.51B2.61B
Account Payables68M74.31M80.85M69.73M97.2M
Short-term Debt229.67M23.43M18.11M78M31.5M
Tax Payables15.14M16.51M23.34M32.46M33.1M
Deferred Revenue8.42M10.23M10.73M10.85M0
Other Current Liabilities297.76M109.23M98.97M51.2M553.4M
Total Current Liabilities696.97M297.4M334.98M392.13M808.1M
Long-term Debt9.85M518.07M568.54M549.62M393.5M
Deferred Tax Liabilities7.73M8.52M11.57M10.92M9.6M
Deferred Revenue (Non-current)00000
Other Non-current Liabilities155.84M233.62M191.45M193.36M146.6M
Total Non-current Liabilities209.34M789.75M816.95M794.01M598M
Total Liabilities906.31M1.09B1.15B1.19B1.41B
Common Stock82.3M82.42M82.53M83.16M0
Retained Earnings(897.78M)(984.03M)(966.48M)(903.25M)0
Accumulated OCI(7.18M)(48.12M)(27.88M)(80.17M)0
Other Stockholders Equity00001.2B
Minority Interest00000
Total Equity1.29B1.21B1.28B1.32B1.2B
Total Debt286.7M580.43M640.4M676.77M473.3M
Net Debt78.71M366.26M373.9M247.92M(162.3M)

LivaNova PLC

NASDAQ:LIVN

Intrinsic Alpha fair value

Locked

Current Price

$94.54

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.